CD Skripsi
Sintesis Dan Studi Molecular Docking Senyawa Hidrazon (E)-2-((E)-3-(2-Florofenil)-1-(2-Hidroksi Naftalen-1-Il)Alliliden)-N-Fenilhidrazin Karbotioamida Sebagai Antikanker Payudara
Hydrazone is an organic compound that has an azomethine group –NHN=CH- which has various biological activities, one of which is as an anticancer agent. The hydrazone compound (E)-2-((E)-3-(2-fluorophenyl)-1-(2-hydroxyinaphtalene-1- yl)allylidene)-N-phenylhydrazine carbothioamide has been succesfully synthesized through condensation reaction of the chalcone (6) with 4-phenylthiosemicarbazide using a stirring and heating method in a glass reactor tube. The hydrazone compound (8) obtained was red with a yield percentage of 70.52%. The structure of hydrazone was confirmed through spectroscopic characterization of UV, FTIR, HRMS, 1H-NMR, and 13C-NMR. The pure synthesized compound was tested for it’s activity as an anti-breast cancer agent by molecular docking studies carried out on the estrogen receptor α (PDB ID: 3ERT) with 4-hydroxytamoxifen (4OHT) as natural ligands. The docking results showed that the synthesized hydrazone compound has similar amino acid interaction with 4-OHT, but free bond energy value and inhibition constant of hydrazone compound are -10.58 kcal/mol and 17,55 nM showed hydrazone compound not as effective compared to natural ligand 4-OHT.
Tidak tersedia versi lain